Method and platform standardization in MRM-based quantitative plasma proteomics
- PMID: 23933160
- DOI: 10.1016/j.jprot.2013.07.026
Method and platform standardization in MRM-based quantitative plasma proteomics
Abstract
There exists a growing demand in the proteomics community to standardize experimental methods and liquid chromatography-mass spectrometry (LC/MS) platforms in order to enable the acquisition of more precise and accurate quantitative data. This necessity is heightened by the evolving trend of verifying and validating candidate disease biomarkers in complex biofluids, such as blood plasma, through targeted multiple reaction monitoring (MRM)-based approaches with stable isotope-labeled standards (SIS). Considering the lack of performance standards for quantitative plasma proteomics, we previously developed two reference kits to evaluate the MRM with SIS peptide approach using undepleted and non-enriched human plasma. The first kit tests the effectiveness of the LC/MRM-MS platform (kit #1), while the second evaluates the performance of an entire analytical workflow (kit #2). Here, these kits have been refined for practical use and then evaluated through intra- and inter-laboratory testing on 6 common LC/MS platforms. For an identical panel of 22 plasma proteins, similar concentrations were determined, regardless of the kit, instrument platform, and laboratory of analysis. These results demonstrate the value of the kit and reinforce the utility of standardized methods and protocols.
Biological significance: The proteomics community needs standardized experimental protocols and quality control methods in order to improve the reproducibility of MS-based quantitative data. This need is heightened by the evolving trend for MRM-based validation of proposed disease biomarkers in complex biofluids such as blood plasma. We have developed two kits to assist in the inter- and intra-laboratory quality control of MRM experiments: the first kit tests the effectiveness of the LC/MRM-MS platform (kit #1), while the second evaluates the performance of an entire analytical workflow (kit #2). In this paper, we report the use of these kits in intra- and inter-laboratory testing on 6 common LC/MS platforms. This article is part of a Special Issue entitled: Standardization and Quality Control in Proteomics.
Keywords: Kits; LC/MS/MS; Multiple reaction monitoring; Plasma; Quantitative proteomics; Standardization.
© 2013.
Similar articles
-
Enhanced sensitivity and multiplexing with 2D LC/MRM-MS and labeled standards for deeper and more comprehensive protein quantitation.J Proteomics. 2014 Jun 25;106:113-24. doi: 10.1016/j.jprot.2014.04.024. Epub 2014 Apr 24. J Proteomics. 2014. PMID: 24769237
-
Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS).Mol Cell Proteomics. 2013 Sep;12(9):2623-39. doi: 10.1074/mcp.M112.027078. Epub 2013 May 20. Mol Cell Proteomics. 2013. PMID: 23689285 Free PMC article.
-
Pre-analytical and analytical variability in absolute quantitative MRM-based plasma proteomic studies.Bioanalysis. 2013 Nov;5(22):2837-56. doi: 10.4155/bio.13.245. Bioanalysis. 2013. PMID: 24256362 Review.
-
Protocol for Standardizing High-to-Moderate Abundance Protein Biomarker Assessments Through an MRM-with-Standard-Peptides Quantitative Approach.Adv Exp Med Biol. 2016;919:515-530. doi: 10.1007/978-3-319-41448-5_24. Adv Exp Med Biol. 2016. PMID: 27975233 Review.
-
Standardized protocols for quality control of MRM-based plasma proteomic workflows.J Proteome Res. 2013 Jan 4;12(1):222-33. doi: 10.1021/pr300893w. Epub 2012 Dec 17. J Proteome Res. 2013. PMID: 23245390
Cited by
-
Proteome Multimarker Panel With Multiple Reaction Monitoring-Mass Spectrometry for Early Detection of Hepatocellular Carcinoma.Hepatol Commun. 2020 Mar 13;4(5):753-768. doi: 10.1002/hep4.1500. eCollection 2020 May. Hepatol Commun. 2020. PMID: 32363324 Free PMC article.
-
Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric labeling quantitative method.J Proteome Res. 2014 Dec 5;13(12):6058-66. doi: 10.1021/pr500934u. Epub 2014 Nov 24. J Proteome Res. 2014. PMID: 25393578 Free PMC article.
-
Serum fibronectin distinguishes the early stages of hepatocellular carcinoma.Sci Rep. 2017 Aug 25;7(1):9449. doi: 10.1038/s41598-017-09691-3. Sci Rep. 2017. PMID: 28842594 Free PMC article.
-
Nitric oxide mediated inhibition of antigen presentation from DCs to CD4+ T cells in cancer and measurement of STAT1 nitration.Sci Rep. 2017 Nov 13;7(1):15424. doi: 10.1038/s41598-017-14970-0. Sci Rep. 2017. PMID: 29133913 Free PMC article.
-
Proteome Multimarker Panel for the Early Detection of Hepatocellular Carcinoma: Multicenter Derivation, Validation, and Comparison.ACS Omega. 2022 Aug 19;7(34):29934-29943. doi: 10.1021/acsomega.2c02926. eCollection 2022 Aug 30. ACS Omega. 2022. PMID: 36061641 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources